Table 2.
Distributions of the EQ-5D-5L index and subscale scores of EORTC QLQ-C30 and FACT-G
| Minimum | 5% | 25% | Median | 75% | 95% | Maximum | |
|---|---|---|---|---|---|---|---|
| EORTC QLQ-C30 analysis | |||||||
| EQ-5D-5L index (Japan) | − 0.025 | 0.437 | 0.691 | 0.823 | 0.895 | 1 | 1 |
| EORTC QLQ-C30 | |||||||
| Physical functioning | 0 | 33.3 | 66.7 | 86.7 | 93.3 | 100 | 100 |
| Role functioning | 0 | 0 | 66.7 | 83.3 | 100 | 100 | 100 |
| Emotional functioning | 0 | 44.4 | 75 | 83.3 | 100 | 100 | 100 |
| Cognitive functioning | 0 | 33.3 | 66.7 | 83.3 | 100 | 100 | 100 |
| Social functioning | 0 | 33.3 | 66.7 | 83.3 | 100 | 100 | 100 |
| Global health status | 0 | 16.7 | 50 | 66.7 | 83.3 | 100 | 100 |
| Fatigue | 0 | 0 | 22.2 | 33.3 | 55.6 | 77.8 | 100 |
| Nausea and vomiting | 0 | 0 | 0 | 0 | 16.7 | 33.3 | 100 |
| Pain | 0 | 0 | 0 | 16.7 | 33.3 | 66.7 | 100 |
| Dyspnea | 0 | 0 | 0 | 33.3 | 33.3 | 100 | 100 |
| Insomnia | 0 | 0 | 0 | 33.3 | 33.3 | 66.7 | 100 |
| Appetite loss | 0 | 0 | 0 | 0 | 33.3 | 100 | 100 |
| Constipation | 0 | 0 | 0 | 33.3 | 33.3 | 66.7 | 100 |
| Diarrhea | 0 | 0 | 0 | 0 | 33.3 | 66.7 | 100 |
| Financial difficulties | 0 | 0 | 0 | 33.3 | 33.3 | 100 | 100 |
| FACT-G analysis | |||||||
| EQ-5D-5L index (Japan) | − 0.025 | 0.436 | 0.691 | 0.823 | 0.895 | 1 | 1 |
| FACT-G | |||||||
| Physical well-being | 1 | 9 | 16 | 22 | 25 | 28 | 28 |
| Social/family well-being | 0 | 5 | 14 | 18 | 22 | 26.8 | 28 |
| Emotional well-being | 0 | 7 | 13 | 17 | 20 | 23 | 24 |
| Functional well-being | 0 | 6 | 13 | 17 | 22 | 27 | 28 |
EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; FACT-G, Functional Assessment of Cancer Therapy General